Living up to this law of nature, the tiny country of Estonia continues to punch above its weight. The country’s uniquely entrepreneurial environment, solid scientific and research foundation, and strongly interconnected scientific community provide the perfect backdrop for breakthroughs ranging from Europe’s first CE-marked cancer polygenic risk score tests to viral transport solution technology that enables direct real-time PCR without the need of any nucleic acid extraction or purification methods.
Meet the leading-edge biotech companies participating at BIO Digital 2021 and pushing boundaries with their in-depth knowledge and constant drive to improve the world through science.
Antegenes has developed and brought into healthcare novel polygenic risk score based genetic tests to estimate the risk of common cancers. The polygenic risk score sums up information over hundreds to thousands of genetic variants in the human genome. By combining the polygenic risk score with a person’s background (origin, age, and gender), we are able to calculate a person’s risk of developing cancer and provide medical advice on prevention and early detection. By implementing precision prevention, it is possible to reduce the incidence and impact of cancer and achieve a longer life.
TFTAK is a CRO based on extensive use of modern analytical methods, systems biology and synthetic biology principles, aiming at developing innovative solutions for the food and biotechnology industry. TFTAK has a state-of-the-art laboratory and highly qualified personnel. We have in-depth knowledge about microbial cultivation and understanding of molecules and their behavior.
HansaBioMed Life Sciences (HBM-LS) is a company dedicated to R&D and innovation in the field of Extracellular Vesicles (EVs). Our mission is to develop and commercialize proprietary platforms, tools and services for EV research. With over 10 years of experience, we provide our customers high quality services and the widest portfolio of products dedicated to the research in EV field. We are also leading product development and scientific grants and are partner in several H2020 projects.
Nanobot Medical is an award-winning creative scientific storytelling company that values our clients’ time and money. We transform complex life science and medical product-related concepts into scientifically accurate, easy-to-understand, focused visual media. We specialize in digital solutions like 3D medical animations | illustrations, scientific VR/AR/MR, AI chatbots, remote e-detailing platforms for innovative virtual marketing, and education strategies.
Quretec is a software development company founded in 2006, building Qure Platform software, that is intended mostly for web-based secure health and personal data management, supporting related processes with customizable forms.
Solis BioDyne has been trusted life-science business partner over 26 years. High-quality molecular biology reagents, extensive standards for production and service have made us a trademark worldwide. Being an R&D driven manufacturer, gives flexibility and time-to-market leverage to come out with a product and solution, that meets your specific needs. Our DNA polymerases, (q)PCR Mixes and reverse transcription reagents are stable at room temperature for 30 days.
A merger of various biotechnology companies, ZipPrime was established in 2014 in Turkey, and in 2019 in Estonia. Since its inception, supported by several national and European grants, ZipPrime has developed various technologies ranging from cell-free preservation and extraction technologies to nucleic acid isolation technologies and viral focused product lines.
ZipPrime’s viral transport solution is intended for collection, transport and inactivation of clinical specimens containing viruses under safe conditions, which is extremely important for working with SARS-CoV-2, among others. Also, ZipPrime’s viral transport solution technology enables direct real-time PCR without the need of any nucleic acid extraction or purification methods.
TBD-Biodiscovery provides CDMO services for pharma and biotech industries worldwide. TBD develops, manufactures and sells active pharmaceutical ingredients (API). In few years, our manufacturing capacity will be increased up to 200 kg per batch with reactors of 2500 L. TBD-Biodiscovery is one of very few companies in the world which has know how for manufacturing WHITE Luciferin and WHITE Luciferin K Salt.
Head of Sales Department
+372 747 7001[email protected]
10 Jun 2021